Clinical trials
Phase 3 Hyperphosphatemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alebund Pharmaceuticals | 2 |
| Chen Jing | 1 |
| Panion & BF Biotech Inc. | 1 |
| Sanofi | 1 |
| Sinomune Pharmaceutical Co., Ltd | 1 |
| Vifor Fresenius Medical Care Renal Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 7 |
| Renal Insufficiency, Chronic | 4 |
| Kidney Failure, Chronic | 2 |
| Kidney Diseases | 1 |
| Phosphorus Metabolism Disorders | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.